| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $27.45B | +10.3% |
| Cost of Revenue | $17.13B | +11.4% |
| R&D Expense | $797.0M | +0.4% |
| SG&A Expense | $4.31B | +5.7% |
| Pre-tax Income | $4.93B | +8.0% |
| Income Tax | $841.0M | +9.5% |
| Net Income | $4.09B | +7.7% |
| EPS (Basic) | $10.48 | +9.9% |
| EPS (Diluted) | $10.45 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $622.0M | +12.1% |
| Short-term Investments | $181.0M | -88.1% |
| Accounts Receivable | $5.39B | +16.6% |
| Inventory | $4.72B | +11.7% |
| Current Assets | $12.36B | +4.7% |
| Total Assets | $41.25B | +7.5% |
| Current Liabilities | $9.37B | +19.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $4.47B | +3.4% |
| Capital Expenditures | $919.0M | +13.7% |
| Investing Cash Flow | -$1.10B | -306.3% |
| Financing Cash Flow | -$3.17B | +19.4% |
| Free Cash Flow | $3.55B | +1.0% |
| +10.0% |
| Long-term Debt |
| $9.89B |
| +8.1% |
| Stockholders' Equity | $19.43B | +5.1% |